In bladder cancer, MEG3 was found to function as a ceRNA for PTEN by competitively binding miR-494, thus repressing the proliferation, migration and invasion and promoting the apoptosis of tumour cells [57]. This evidence concerns the gene MEG3 and urinary bladder carcinoma.